Aesthetics reports on the highlights from The Aesthetic Medicine Congress (TAMC) in association with the British College of Aesthetic Medicine
Following the news that global biopharmaceutical group Ipsen has implemented a new cell-based test for toxin products, Aesthetics looks at patient perceptions towards animal testing.
In the second of a two-part article, Dr Souphiyeh Samizadeh explores the different technologies of dermal fillers and their characteristics to aid product selection.
In the first of a two-part article, Dr Souphiyeh Samizadeh discusses the basic characteristics of hyaluronic acid fillers to aid product selection
Professor Andy Pickett and independent aesthetic business consultant Emma Miller discuss research into the use of botulinum toxin for the treatment of obesity
From February 14-17, 900 aesthetic professionals were given the opportunity to observe and work alongside aesthetic practitioner Dr Mauricio de Maio as part of the MD Codes Tour, supported by the Allergan Medical Institute (AMI).
Global pharmaceutical company Allergan has launched a new advertising campaign for its dermal filler Juvéderm which will be launched internationally in Spring 2019.
